Login

MariMed Inc. (OTC: MRMD) is a multi-state cannabis operator headquartered in Norwood, Massachusetts that cultivates, produces, and dispenses medicinal and adult-use cannabis across multiple U.S. states. Revenue is generated primarily through retail dispensary sales, with wholesale distribution of proprietary branded products as a secondary channel. The company operates a vertically integrated model, running cultivation and production facilities alongside retail dispensaries branded under the Thrive name following a national rebranding completed in 2025. MariMed also licenses its proprietary brands in select domestic markets, though the 10-K filing for FY2025 notes licensing revenues are not material to overall results. In 2025, the company expanded into hemp-derived cannabinoid products under the 2018 Farm Bill framework. State-level operations include Massachusetts, Delaware, and Illinois, among others. The company entered cannabis as an advisory and real estate management firm before transitioning to direct ownership and operations.

Products & Services

Thrive-branded retail dispensaries selling cannabis flower, concentrates, edibles, and other precision-dosed products. Proprietary brands include Betty's Eddies (edibles). Cultivation and production facilities supply both retail and wholesale channels. Home delivery offered in Massachusetts and Delaware. Hemp-derived cannabinoid products introduced in 2025.

Revenue Model

Retail dispensary sales are the primary revenue driver. Secondary revenue comes from wholesale distribution of proprietary branded products to other state-licensed operators, brand licensing fees in select domestic markets (noted as not material in FY2025 10-K), and hemp-derived cannabinoid product sales launched during 2025.

Customers & Markets

Medical cannabis patients and adult-use recreational consumers in state-licensed markets. End demand is retail consumer-facing, served through dispensaries and home delivery. Wholesale customers are other state-licensed cannabis operators who carry MariMed-branded products.

Geographic Exposure

Operations in Massachusetts (three retail dispensaries, cultivation and production facilities in New Bedford and Quincy), Delaware (Thrive-branded dispensaries in Wilmington and Lewes, cultivation in Milford, production kitchen in Wilmington, acquired March 2025), and Illinois (five Thrive-branded dispensaries in Metropolis, Casey, Mt. Vernon, Anna, and Harrisburg). Maryland operations referenced via Hagerstown cultivation facility expansion.

Financial Snapshot

Revenue
TTM
$161.5M
Gross Margin
TTM
36.13%
Net Income
TTM
-$12.63M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
95.34%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$53.45M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$5.668M

Stock Price

Loading...
Market Cap: $27.15 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support